Y-27632 dihydrochloride
To Order Contact us: stephen@expresspharmapulse.com
 Y-27632, dihydrochloride |
|
1596-1 |
Biovision |
each |
EUR 210 |
Y-27632, dihydrochloride |
|
1596-5 |
Biovision |
each |
EUR 555.6 |
Y-27632, dihydrochloride |
|
1596-50 |
Biovision |
each |
EUR 2962.8 |
 Y-27632 |
|
E1KS1049 |
EnoGene |
2 mg |
EUR 390 |
Y-27632 |
|
B1293-10 |
ApexBio |
10 mg |
EUR 170.4 |
|
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
Y-27632 |
|
B1293-200 |
ApexBio |
200 mg |
EUR 1284 |
|
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
Y-27632 |
|
B1293-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
|
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
Y-27632 |
|
B1293-50 |
ApexBio |
50 mg |
EUR 505.2 |
|
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
 EZSolution? Y-27632 |
|
1784-5 |
Biovision |
each |
EUR 535.2 |
) Y 27632 (ROCK kinase inhibitor) |
|
SIH-486-1MG |
Stressmarq |
1 mg |
EUR 178.8 |
|
|
|
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble. |
Y 27632 (ROCK kinase inhibitor) |
|
SIH-486-5MG |
Stressmarq |
5 mg |
EUR 393.6 |
|
|
|
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble. |
 EZSolution? Y-27632, Sterile-Filtered |
|
1994-1 |
Biovision |
each |
EUR 430.8 |
 Y-39983 dihydrochloride |
|
B1176-10 |
ApexBio |
10 mg |
EUR 494.4 |
|
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
Y-39983 dihydrochloride |
|
B1176-100 |
ApexBio |
100 mg |
EUR 2881.2 |
|
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
Y-39983 dihydrochloride |
|
B1176-50 |
ApexBio |
50 mg |
EUR 1796.4 |
|
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
 SNRPF Polyclonal Antibody |
|
27632-100ul |
SAB |
100ul |
EUR 302.4 |
SNRPF Polyclonal Antibody |
|
27632-50ul |
SAB |
50ul |
EUR 224.4 |
 JNJ-26481585 |
|
27632-1 |
BPS Bioscience |
5 mg |
EUR 235 |
|
Description: JNJ-26481585, also known as Quisinostat, is a potent pan-HDAC inhibitor. JNJ-26481585 induces histone acetylationand inhibits cancer cell proliferation. |
JNJ-26481585 |
|
27632-2 |
BPS Bioscience |
10 mg |
EUR 305 |
|
Description: JNJ-26481585, also known as Quisinostat, is a potent pan-HDAC inhibitor. JNJ-26481585 induces histone acetylationand inhibits cancer cell proliferation. |
JNJ-26481585 |
|
27632-3 |
BPS Bioscience |
50 mg |
EUR 495 |
|
Description: JNJ-26481585, also known as Quisinostat, is a potent pan-HDAC inhibitor. JNJ-26481585 induces histone acetylationand inhibits cancer cell proliferation. |
 Cefotiam Dihydrochloride |
|
C095-100MG |
TOKU-E |
100 mg |
EUR 278.4 |
Cefotiam Dihydrochloride |
|
C095-50MG |
TOKU-E |
50 mg |
EUR 172.8 |
 Chlorhexidine Dihydrochloride |
|
C157-25G |
TOKU-E |
25 g |
EUR 222 |
Chlorhexidine Dihydrochloride |
|
C157-5G |
TOKU-E |
5 g |
EUR 86.4 |
 Retigabine dihydrochloride |
|
A3758-10 |
ApexBio |
10 mg |
EUR 164.4 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|
A3758-100 |
ApexBio |
100 mg |
EUR 522 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|
A3758-5 |
ApexBio |
5 mg |
EUR 126 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|
A3758-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 170.4 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|
A3758-50 |
ApexBio |
50 mg |
EUR 325.2 |
|
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
 Veliparib dihydrochloride |
|
A3958-10 |
ApexBio |
10 mg |
EUR 177.6 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|
A3958-200 |
ApexBio |
200 mg |
EUR 1002 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|
A3958-5 |
ApexBio |
5 mg |
EUR 150 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|
A3958-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 139.2 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|
A3958-50 |
ApexBio |
50 mg |
EUR 421.2 |
|
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
 Ethambutol dihydrochloride |
|
E005-100G |
TOKU-E |
100 g |
EUR 508.8 |
Ethambutol dihydrochloride |
|
E005-25G |
TOKU-E |
25 g |
EUR 171.6 |
 Antipain, dihydrochloride |
|
ADJ692 |
Bio Basic |
5mg |
EUR 110.53 |
|
|
 Naftopidil Dihydrochloride |
|
E1KS1387 |
EnoGene |
25mg |
EUR 296.4 |
 GGACK Dihydrochloride |
|
1847-5 |
Biovision |
5 mg |
EUR 382.8 |
|
|
|
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
 AT7867 dihydrochloride |
|
A3199-10 |
ApexBio |
10 mg |
EUR 408 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
AT7867 dihydrochloride |
|
A3199-100 |
ApexBio |
100 mg |
EUR 2210.4 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
AT7867 dihydrochloride |
|
A3199-5 |
ApexBio |
5 mg |
EUR 320.4 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
AT7867 dihydrochloride |
|
A3199-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 344.4 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
AT7867 dihydrochloride |
|
A3199-50 |
ApexBio |
50 mg |
EUR 1537.2 |
|
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
 Canertinib dihydrochloride |
|
A3276-10 |
ApexBio |
10 mg |
EUR 129.6 |
|
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
Canertinib dihydrochloride |
|
A3276-100 |
ApexBio |
100 mg |
EUR 226.8 |
|
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
Canertinib dihydrochloride |
|
A3276-50 |
ApexBio |
50 mg |
EUR 177.6 |
|
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
 Inolitazone dihydrochloride |
|
A3499-5 |
ApexBio |
5 mg |
EUR 837.6 |
|
Description: Description:IC50 Value: 0.8 nM [1]Inolitazone(RS5444) is a novel high-affinity PPARgamma agonist, which activates PPARgamma with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARgamma. |
 DMPQ Dihydrochloride |
|
20-abx076714 |
Abbexa |
|
|
|
|
 H89 Dihydrochloride |
|
20-abx076747 |
Abbexa |
|
|
|
|
 Vatalanib Dihydrochloride |
|
20-abx076544 |
Abbexa |
|
|
|
|
 Alexidine dihydrochloride |
|
A4542-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
|
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
Alexidine dihydrochloride |
|
A4542-50 |
ApexBio |
50 mg |
EUR 220.8 |
|
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
GGACK Dihydrochloride |
|
A2582-5 |
ApexBio |
5 mg |
EUR 282 |
|
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
 PPACK Dihydrochloride |
|
A2588-10 |
ApexBio |
10 mg |
EUR 423.6 |
|
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
PPACK Dihydrochloride |
|
A2588-25 |
ApexBio |
25 mg |
EUR 908.4 |
|
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
PPACK Dihydrochloride |
|
A2588-5 |
ApexBio |
5 mg |
EUR 265.2 |
|
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
 LDK378 dihydrochloride |
|
A3544-10 |
ApexBio |
10 mg |
EUR 186 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
LDK378 dihydrochloride |
|
A3544-100 |
ApexBio |
100 mg |
EUR 331.2 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
LDK378 dihydrochloride |
|
A3544-5 |
ApexBio |
5 mg |
EUR 150 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
LDK378 dihydrochloride |
|
A3544-5.1 |
ApexBio |
10 mM (in 1mL H2O) |
EUR 184.8 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
LDK378 dihydrochloride |
|
A3544-50 |
ApexBio |
50 mg |
EUR 240 |
|
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM. |
 Mibefradil dihydrochloride |
|
A3605-10 |
ApexBio |
10 mg |
EUR 315.6 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
Mibefradil dihydrochloride |
|
A3605-25 |
ApexBio |
25 mg |
EUR 663.6 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
Mibefradil dihydrochloride |
|
A3605-5 |
ApexBio |
5 mg |
EUR 201.6 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
Mibefradil dihydrochloride |
|
A3605-50 |
ApexBio |
50 mg |
EUR 1195.2 |
|
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris. |
 Pramipexole dihydrochloride |
|
A3733-20 |
ApexBio |
20 mg |
EUR 129.6 |
|
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
Pramipexole dihydrochloride |
|
A3733-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
|
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
Pramipexole dihydrochloride |
|
A3733-50 |
ApexBio |
50 mg |
EUR 157.2 |
|
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors. |
 Piperazine Dihydrochloride |
|
abx180858-100g |
Abbexa |
100 g |
EUR 276 |
|
|
Pramipexole dihydrochloride |
|
20-abx180860 |
Abbexa |
-
EUR 543.60
-
EUR 276.00
-
EUR 444.00
|
|
|
|
 Bisantrene dihydrochloride |
|
B2736-25 |
Biovision |
25 mg |
EUR 576 |
Bisantrene dihydrochloride |
|
B2736-5 |
Biovision |
5 mg |
EUR 199.2 |
 Cystamine dihydrochloride |
|
B2982-1 |
Biovision |
1 g |
EUR 132 |
Cystamine dihydrochloride |
|
B2982-5 |
Biovision |
5 g |
EUR 351.6 |
 Cetirizine dihydrochloride |
|
B2993-100 |
Biovision |
100mg |
EUR 132 |
Cetirizine dihydrochloride |
|
B2993-500 |
Biovision |
500mg |
EUR 344.4 |
 SA4503 dihydrochloride |
|
B3046-25 |
Biovision |
25 mg |
EUR 612 |
SA4503 dihydrochloride |
|
B3046-5 |
Biovision |
5 mg |
EUR 199.2 |
 Vanoxerine dihydrochloride |
|
B3248-10 |
ApexBio |
10 mg |
EUR 141.6 |
|
Description: Vanoxerine is an antagonist of dopamine transporter (DAT1) with Ki value of 16.9nM [1].As an antagonist of DAT, vanoxerine is developed for treatment of Parkinson's disease and depression but has no effect on these diseases. |
Vanoxerine dihydrochloride |
|
B3248-25 |
ApexBio |
25 mg |
EUR 252 |
|
Description: Vanoxerine is an antagonist of dopamine transporter (DAT1) with Ki value of 16.9nM [1].As an antagonist of DAT, vanoxerine is developed for treatment of Parkinson's disease and depression but has no effect on these diseases. |
Vanoxerine dihydrochloride |
|
B3248-50 |
ApexBio |
50 mg |
EUR 398.4 |
|
Description: Vanoxerine is an antagonist of dopamine transporter (DAT1) with Ki value of 16.9nM [1].As an antagonist of DAT, vanoxerine is developed for treatment of Parkinson's disease and depression but has no effect on these diseases. |
 Spectinomycin dihydrochloride |
|
B3342-1000 |
ApexBio |
1 g |
EUR 180 |
|
Description: Spectinomycin Dihydrochloride is a new parenteral antibiotic prepared from Streptomyces spectabilis. |
Spectinomycin dihydrochloride |
|
B3342-5.1 |
ApexBio |
10 mM (in 1mL H2O) |
EUR 201.6 |
|
Description: Spectinomycin Dihydrochloride is a new parenteral antibiotic prepared from Streptomyces spectabilis. |
Spectinomycin dihydrochloride |
|
B3342-5000 |
ApexBio |
5 g |
EUR 339.6 |
|
Description: Spectinomycin Dihydrochloride is a new parenteral antibiotic prepared from Streptomyces spectabilis. |
 Pentamidine dihydrochloride |
|
B3416-50 |
ApexBio |
50 mg |
EUR 153.6 |
|
Description: Pentamidine Dihydrochloride(MP601205 dihydrochloride) is an antimicrobial agent. |
 IT1t dihydrochloride |
|
B5650-10 |
ApexBio |
10 mg |
EUR 385.2 |
|
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
IT1t dihydrochloride |
|
B5650-100 |
ApexBio |
100 mg |
EUR 2100 |
|
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
IT1t dihydrochloride |
|
B5650-25 |
ApexBio |
25 mg |
EUR 710.4 |
|
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
IT1t dihydrochloride |
|
B5650-5 |
ApexBio |
5 mg |
EUR 243.6 |
|
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
IT1t dihydrochloride |
|
B5650-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 261.6 |
|
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
IT1t dihydrochloride |
|
B5650-50 |
ApexBio |
50 mg |
EUR 1232.4 |
|
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12. |
 Mizolastine dihydrochloride |
|
B1116-100 |
ApexBio |
100 mg |
EUR 285.6 |
|
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. |
Mizolastine dihydrochloride |
|
B1116-200 |
ApexBio |
200 mg |
EUR 468 |
|
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. |
Mizolastine dihydrochloride |
|
B1116-500 |
ApexBio |
500 mg |
EUR 783.6 |
|
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions. |
Cystamine dihydrochloride |
|
B5785-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 129.6 |
Cystamine dihydrochloride |
|
B5785-50 |
ApexBio |
50 mg |
EUR 134.4 |
 Fluphenazine dihydrochloride |
|
B6132-100 |
ApexBio |
100 mg |
EUR 180 |
|
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons. |
Fluphenazine dihydrochloride |
|
B6132-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 201.6 |
|
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons. |
 Dilazep dihydrochloride |
|
B6316-50 |
ApexBio |
50 mg |
EUR 321.6 |
 Dimaprit dihydrochloride |
|
B6328-100 |
ApexBio |
100 mg |
EUR 321.6 |
 Naloxonazine dihydrochloride |
|
B6366-10 |
ApexBio |
10 mg |
EUR 265.2 |
Naloxonazine dihydrochloride |
|
B6366-50 |
ApexBio |
50 mg |
EUR 926.4 |
 Piribedil dihydrochloride |
|
B6557-10 |
ApexBio |
10 mg |
EUR 166.8 |
Piribedil dihydrochloride |
|
B6557-100 |
ApexBio |
100 mg |
EUR 258 |
Piribedil dihydrochloride |
|
B6557-200 |
ApexBio |
200 mg |
EUR 404.4 |
Piribedil dihydrochloride |
|
B6557-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 180 |
Piribedil dihydrochloride |
|
B6557-50 |
ApexBio |
50 mg |
EUR 223.2 |
Piribedil dihydrochloride |
|
B6557-500 |
ApexBio |
500 mg |
EUR 675.6 |
 Pirenzepine dihydrochloride |
|
B6582-100 |
ApexBio |
100 mg |
EUR 160.8 |
Pirenzepine dihydrochloride |
|
B6582-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 180 |
Pirenzepine dihydrochloride |
|
B6582-500 |
ApexBio |
500 mg |
EUR 219.6 |
 Telenzepine dihydrochloride |
|
B6606-10 |
ApexBio |
10 mg |
EUR 193.2 |
Telenzepine dihydrochloride |
|
B6606-50 |
ApexBio |
50 mg |
EUR 576 |
 DMPQ dihydrochloride |
|
B6642-10 |
ApexBio |
10 mg |
EUR 223.2 |
DMPQ dihydrochloride |
|
B6642-5 |
ApexBio |
5 mg |
EUR 184.8 |
 GNTI dihydrochloride |
|
B6669-10 |
ApexBio |
10 mg |
EUR 459.6 |
GNTI dihydrochloride |
|
B6669-50 |
ApexBio |
50 mg |
EUR 1746 |
 1400W dihydrochloride |
|
B6730-10 |
ApexBio |
10 mg |
EUR 170.4 |
|
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response. |
1400W dihydrochloride |
|
B6730-100 |
ApexBio |
100 mg |
EUR 873.6 |
|
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response. |
1400W dihydrochloride |
|
B6730-50 |
ApexBio |
50 mg |
EUR 525.6 |
|
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response. |
 Rimcazole dihydrochloride |
|
B6765-10 |
ApexBio |
10 mg |
EUR 388.8 |
Y-27632 dihydrochloride
